Combined metabolomic and metagenomic analysis reveals inflammatory bowel disease diversity in pediatric and adult patients

Figure 8 Difference between the taxonomic composition of the gut microbiome of pediatric and adult patients with inflammatory bowel disease. A: Results of identifying differentially abundant species between pediatric and adult inflammatory bowel disease patient groups using Maalsin2 with the following thresholds: Minimum abundance = 0.01, minimum prevalence = 0.25, maximum significance = 0.05; B: Results of identifying biomarker species of pediatric and adult inflammatory bowel disease patient groups using linear discriminant analysis effect size. The colors indicate biomarker species for the studied groups. IBD: Inflammatory bowel disease; LDA: Linear discriminant analysis.